Last reviewed · How we verify
Effect of F. Prausnitzii on Glycemic Control
The microbiota is associated with a wide spectrum of diseases including diabetes and non-alcoholic fatty liver disease. In this study we will investigate if the bacteria F. prausnitzii, which is a part of the human gut microbiota, can improve metabolic parameters in subjects with impaired glucose control.
Details
| Lead sponsor | MetaboGen AB |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 176 |
| Start date | Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Dec 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Pre Diabetes
- Impaired Glucose Tolerance
- Non-Alcoholic Fatty Liver Disease
Interventions
- F. prausnitzii and D. piger
- Placebo
Countries
Sweden